(lp0
S"Eli Lilly &amp; Co.'s Recent Developments Market Realist - Feb 23, 2017 Eli Lilly and Boehringer Ingelheim also launched Basaglar in the US market. LLY launched Taltz in Japan for psoriasis and psoriatic arthritis.Eli Lilly and Company  Surged 1.83% - TopChronicleEli Lilly and Company  Shares Bought by Meiji Yasuda Asset Management Co Ltd. - BNB Daily "
p1
aS'Eli Lilly &amp; Co.  Completes Takeover of CoLucid Pharmaceuticals  StreetInsider.com - Mar 1, 2017 Eli Lilly and Company  today announced the successful completion of its acquisition of CoLucid Pharmaceuticals, Inc. .Lilly Completes Acquisition - Inside INdiana Business'
p2
aS"Eli Lilly &amp; Co. Part of Lawsuit Over Insulin  Investopedia - Jan 30, 2017 are in the cross hairs. The New York Times reported a federal lawsuit was filed in Massachusetts alleging the companies conspired to drive up prices on insulin.Sanofi, Novo Nordisk and Lilly named in patients' price fixing suit - Reuters"
p3
aS'Eli Lilly and Co  &amp; CIT Group Inc ClickLancashire - Mar 17, 2017 Eli Lilly and Company  saw its share price trade relatively negative in the recent trading session. The stock traded at a volume of 5.01 million shares.Better Buy: Eli Lilly and Company vs. Pfizer - Motley FoolIs Eli Lilly A Sell After Its 4-Month Run? - Seeking Alpha'
p4
aS'Lilly Turns From One Company Veteran to Another for New CEO Bloomberg - Jul 27, 2016 Over the last eight years, Eli Lilly &amp; Co. relied on a three-decade company veteran to steer it through declining sales and a struggling product pipeline.Eli Lilly &amp; Co.  Chairman, CEO Lechleiter to Retire; Successor Named - StreetInsider.comLilly Reports Second-Quarter 2016 Results, Provides Financial Expectations ... - PR Newswire '
p5
aS'Eli Lilly &amp; Co. Up on Revenue Beat  Investopedia - Jan 31, 2017 This morning, Eli Lilly &amp; Co.  reported fourth quarter 2016 revenue of $5.760 billion and non-GAAP EPS of $0.95.Eli Lilly &amp; Co.  Q4 2016 Results - Earnings Call Transcript - Seeking AlphaEli Lilly stock jumps after fourth quarter earnings release - Medill Reports: Chicago'
p6
aS"Eli Lilly &amp; Co. Surges on Strong FY'17 Guidance  Investopedia - Dec 15, 2016 are jumping higher today after the company updated its FY 2016 financial guidance and expectations for FY 2017. The company continues to expect FY 2016 adjusted earnings per share of $3.50 to $3.60, and revenue of $20.8 billion to $21.2 billion. For FY&nbsp;...Eli Lilly &amp; Co. , Incyte  Announce CHMP Recommendation of ... - StreetInsider.comEli Lilly Gives Bullish Outlook on Revenue and Profit - Wall Street Journal"
p7
aS"Eli Lilly chasing psoriasis jackpot with Taltz Indianapolis Business Journal - 9 hours ago For Lilly, the stakes are high. The company's traditional portfolio of once-brisk-selling products has slid into decline in recent years amid patent expirations."
p8
aS"Eli Lilly shares slide premarket after company says Alzheimer's drug trial failed MarketWatch - Nov 23, 2016 Eli Lilly and Co. shares LLY, +1.68% tumbled 14% in premarket trade Wednesday, after the company said a late-stage trial of a treatment for dementia in patients with Alzheimer's Disease failed to meet its goal."
p9
aS"Eli Lilly and Co.'s 3Q16 Estimates: Oncology Franchise Market Realist - Oct 18, 2016 Eli Lilly and Co.'s  human pharmaceuticals segment also consists of the oncology franchise. The oncology franchise contributes around 18% of total revenues for Lilly.Lilly plans $90 million investment to improve health care in poor areas - Indianapolis StarEli Lilly announces global health care expansion - WISH-TV"
p10
a.